Phase I-II-Projekt

Objective of the Phase I/II working group is the interdisciplinary conception, initiation and coordination of phase I/II studies. The consortium not only conducts investigator initiated, academic studies, but also represents a suitable portal to communicate and coordinate studies initiated by pharmaceutical companies. In addition, an interdisciplinary network has been established to perform an extensive biological study programme.

Due to the participation of a multitude of experienced European study centres, simultaneous recruitment of several trials is feasible.

 

Coordinator: V. Ribrag, Institute Gustave Roussy

 
Corporate Partners - Individual Sponsors
Thu, 27th October 2022 to Sat, 29th October 2022
Annual meeting of the European MCL Network
more dates
Sun, 12th June 2022
The Czernecki Donnelly Prize 2022 was awarded to Lorenz Thurner
more news